Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
235 participants
OBSERVATIONAL
2003-08-11
2011-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI
NCT00166179
Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures
NCT00692991
Cardiac MRI for Metal on Metal Hip Resurfacing
NCT02892448
Validation of MRI Measurement of Cardiac Blood Flow
NCT00417625
Non-Contrast Magnetic Resonance Angiography Assessment of Patients Referred for Transcatheter Aortic Valve Implantation
NCT02007967
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sinus rhythm
* Weight \< 120 kg
* LVEF \> 30%
* Wall motion abnormality on Echo. or LV-gram
* Scheduled for revascularization - Angioplasty/Stent or CABG - within 30 days
Exclusion Criteria
* Frequent atrial or ventricular ectopy
* Severe aortic stenosis or HOCM
* Unstable angina
* Myocardial infarction within 14 days
* Active congestive heart failure
* Pregnancy
* Known allergy to gadolinium
* Contraindication to MRI
21 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic - MITG
INDUSTRY
CHI St. Luke's Health, Texas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Scott D. Flamm, M.D.
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Scott D Flamm, M.D.
Role: PRINCIPAL_INVESTIGATOR
CHI St. Luke's Health, Texas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Luke's Episcopal Hospital
Houston, Texas, United States
St. Luke's Episcopal Location
Houston, Texas, United States
Cliniques Universitaires St. Luc
Brussels, , Belgium
Skejby University Hospital
Aarhus N, , Denmark
Hygeia Hospital
Marousi, , Greece
Siriraj Hospital
Bangkoknoi, Bangkok, Thailand
Cardiac MRI Unit
Leeds, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NDA# 20-937
Identifier Type: -
Identifier Source: secondary_id
IND# 66,506
Identifier Type: -
Identifier Source: secondary_id
1102-02-777
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.